Author

Steffan T. Nawrocki

University of ArizonaORCID 0000-0001-8767-3969Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Benjamin R. LeeiD· 1 shared Claudia M. EspitiaiD· 1 shared Jennifer S. Carew· 1 shared Madison E. GambleiD· 1 shared Maria Janina Carrera EspinozaiD· 1 shared Sruthi SureshkumariD· 1 shared Wei WangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Benjamin R. LeeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyCancer LettersPeer-reviewedJan 30, 2025

REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM kinase activity

Jennifer S. Carew, Claudia M. Espitia, Sruthi Sureshkumar…·Steffan T. Nawrocki

This paper identifies REDD1 as a key determinant of renal cell carcinoma sensitivity to autophagy inhibition and shows that PIM kinase inhibition enhances this sensitivity through REDD1 upregulation.

10 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky